期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

在头颈部肿瘤放疗中PET-CT显示解剖生物靶区的应用进展 被引量：1

下载PDF
导出
作者 戴军 郎锦义
机构地区 泸州医学院附属医院肿瘤科 四川省肿瘤医院
出处 《肿瘤预防与治疗》 2008年第1期96-99,共4页 Journal of Cancer Control And Treatment
基金 四川省科技厅科研项目(05SG022-013)
关键词 PET/CT 解剖生物靶区 放射治疗
分类号 R739.91 [医药卫生—肿瘤]
  • 相关文献

参考文献4

  • 1周克,杨勤,向燕.正电子放射性药物的现状与进展[J].西南军医,2005,7(2):47-48. 被引量：12
  • 2巩合义,于金明.PET乏氧显像预测肿瘤疗效研究进展[J].中华核医学杂志,2005,25(1):57-58. 被引量：12
  • 3Sheng-Chieh Chan,Shu-Hang Ng,Joseph Tung-Chieh Chang,Chien-Yu Lin,Yen-Chao Chen,Yu-Chen Chang,Cheng-Lung Hsu,Hung-Ming Wang,Chun-Ta Liao,Tzu-Chen Yen. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging[J] 2006,European Journal of Nuclear Medicine and Molecular Imaging(9):1032～1040
  • 4Wolfgang A. Weber,Hans-Jürgen Wester,Anca L. Grosu,Michael Herz,Brigitte Dzewas,Horst-Jürgen Feldmann,Michael Molls,Gerhard St?cklin,Markus Schwaiger. O-(2-[18F]Fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study[J] 2000,European Journal of Nuclear Medicine(5):542～549

二级参考文献13

  • 1Ahuja V, Coleman RE, Herndon J, et al.Prognostic significance of FDG-PET imaging in patients with non-small cell lung cancer. Cancer, 1998, 83: 918-924.
  • 2Kubota K, Tada M, Yamada S, et al. Comparison of the distribution of 18F-fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med, 1999, 26: 750-757.
  • 3Koh WJ, Bergman KS, Rasey JS, et al. Evaluation of oxygenation status during fractionated radiotherapy in human non-small cell lung cancers using 18F-fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys,1998, 33: 391-398.
  • 4Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of 18F-fluoromisonidazole: a pretherapy study of 37 patients.Int J Radiat Oncol Biol Phys, 1996, 36: 417-428.
  • 5Lehtio K, Oikonen V, Nyman S, et al. Quantifying tumor hypoxia with 18F-fluoroerythronitroimidazole (18 F-FETNIM) and PET using the tumor to plasma ratio. Eur J Nucl Med Mol Imaging, 2003, 30: 101-108.
  • 6Takahashi N, Fujibayashi Y, Yonekura Y, et al.Evaluation of 62Cu labeled diacetyl-bis ( N-4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med, 2000, 14: 323-328.
  • 7Siim BG, Laux WT, Rutland MD, et al. Scintigraphic imaging of the hypoxia marker 99 Tcm-labeled 2,2'- ( 1,4-diaminobutane ) bis (2-methyl-3-butanone) dioxime (99Tcm labeled HL91; Prognox): non-invasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Res, 2000, 60: 4582-4588.
  • 8Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance:Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2001,49: 1171-1182.
  • 9Haberkom U, Strauss LG, Dimitrakopoulou A,et al. PET studies for fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med,2001, 32:1485-1490.
  • 10Erdi YE, Macapinlac H, Rosenzweig KE, et al.Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med,2000, 27: 861-866.

共引文献21

同被引文献4

引证文献1

二级引证文献1

肿瘤预防与治疗
2008年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部